Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Health Ministry To Review Study Exonerating Tamiflu

This article was originally published in PharmAsia News

Executive Summary

Japan's Health Ministry is expected to cancel a warning it had ordered on Roche's Tamiflu (oseltamivir) for teenagers after a study found no link to mental problems. The government-funded study completed by an Osaka City University professor found that children given the flu vaccine did not demonstrate psychotic behavior beyond normal levels. The ministry will use the study for a report of its own and a review of it by its drug safety committee, according to a ministry official. Tamiflu was required to carry the warning label after reports of psychotic behavior among youth under the age of 18 who had received the drug. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068994

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel